HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES

被引:10
|
作者
RONCO, J
DEDIEU, JF
MARIE, FN
PINTER, A
KACZOREK, M
GIRARD, M
机构
[1] INST PASTEUR,DEPT VIROL,MOLEC VIROL LAB,CNRS,URA 545,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,PARC IND INCARVILLE,F-27101 VAL DE REUIL,FRANCE
[3] PROTEINE PERFORMANCE,F-75018 PARIS,FRANCE
[4] PUBL HLTH RES INST CITY NEW YORK INC,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1992.8.1117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three groups of four rhesus macaques were immunized twice, one month apart with purified recombinant HIV-1LAI gp160 in the presence of either alum, incomplete Freund's adjuvant (IFA), or SAF-1. Two months later, the animals were injected twice again with a synthetic peptide with the sequence of the principal neutralization determinant (PND) of the HIV-1LAI isolate mixed with the same adjuvants. All animals received a booster injection of gp160 and PND peptide at 6 months. This regimen of immunization induced in the SAF-1 and IFA groups a high-titer neutralizing antibody response that declined progressively over the course of the following 6 months. In contrast, only a weak response was observed in the alum group. Neutralizing antibody titers varied as anti-PND titers, suggesting that they were principally targeted to the PND. A shortened immunization protocol comprising two injections of gp160 at 0 and 1 month followed by one injection of PND peptide at 3 months is suggested as optimal for the induction of high titers of HIV-1 neutralizing antibodies in primates.
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 50 条
  • [1] FINE SPECIFICITY OF THE MURINE ANTIBODY-RESPONSE TO HIV-1 GP160 DETERMINED BY SYNTHETIC PEPTIDES WHICH DEFINE SELECTED EPITOPES
    WOLF, H
    WARREN, RQ
    STUNZ, GW
    SHULER, KR
    KANDA, P
    KENNEDY, RC
    MOLECULAR IMMUNOLOGY, 1992, 29 (7-8) : 989 - 998
  • [2] Heparin enhances the furin cleavage of HIV-1 gp160 peptides
    Pasquato, A.
    Dettin, M.
    Basak, A.
    Gambaretto, R.
    Tonin, L.
    Seidah, N. G.
    Di Bello, C.
    FEBS LETTERS, 2007, 581 (30) : 5807 - 5813
  • [3] Immunisation with gp160 in HIV-1 infection
    Flala, C
    Stewart, GT
    LANCET, 1999, 354 (9182): : 948 - 948
  • [4] The Neutralizing Antibody Response to he HIV-1 Env Protein
    Moore, Penny L.
    CURRENT HIV RESEARCH, 2018, 16 (01) : 21 - 28
  • [5] Illustrating the correlations between protein dynamics and glycan shielding of HIV-1 Env gp160
    Suresh, Raghavendran
    Mani, Natesan
    Chakraborty, Srirupa
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 189A - 189A
  • [6] Immunogenicity of HIV-1(LAI) gp160 and env peptides in squirrel monkey Saimiri sciureus using alumine and experimental adjuvants
    Perraut, R
    Chouteau, P
    Moog, C
    Bonnemains, B
    Kieny, MP
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (03): : 434 - 441
  • [7] AFFINITY-PURIFIED, OLIGOMERIC HIV-1 GP160 INDUCES BROADLY NEUTRALIZING ANTIBODIES PREFERENTIALLY REACTIVE WITH NATIVE GP120/GP160
    VANCOTT, TC
    KAMINSKI, R
    MASCOLA, J
    KALYANARAMAN, V
    COX, J
    POLONIS, V
    VEIT, S
    ETTORE, C
    HALLBERG, P
    PATEL, L
    LOWELL, G
    BURKE, D
    RECHTMAN, D
    BIRX, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S150 - S150
  • [8] Immunisation with gp160 in HIV-1 infection -: Reply
    Sandstöm, EG
    Wahren, B
    LANCET, 1999, 354 (9182): : 949 - 949
  • [9] COMPLEMENT ACTIVATION BY GP160 GLYCOPROTEIN OF HIV-1
    THIEBLEMONT, N
    HAEFFNERCAVAILLON, N
    WEISS, L
    MAILLET, F
    KAZATCHKINE, MD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (03) : 229 - 233
  • [10] Expression of HIV-1 env Glycoprotein gp120 and gp160 in Vaccinia Virus System and Their Antigenicity Analysis
    陈元鼎
    Rodolfo Garcia
    Sergio Tisminetzky
    郭仁
    Francisco E.Baralle
    Chinese Medical Sciences Journal, 1997, (02) : 132 - 132